Gene · 865
Papers3,690
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 3,690
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dysregulation of Mitochondrial Translation Caused by CBFB Deficiency Cooperates with Mutant PIK3CA and Is a Vulnerability in Breast Cancer. | Cancer Res | 2023 | 36799863 | PubTator, text mining | PubMed |
| Long Noncoding RNA Expression Independently Predicts Outcome in Pediatric Acute Myeloid Leukemia. | J Clin Oncol | 2023 | 36795987 | PubTator, text mining | PubMed |
| Clinical utility of genomic profiling of AML using paraffin-embedded bone marrow clots: HM-SCREEN-Japan 01. | Cancer Sci | 2023 | 36793248 | PubTator, text mining | PubMed |
| Spermatogenesis associated serine rich 2 like plays a prognostic factor and therapeutic target in acute myeloid leukemia by regulating the JAK2/STAT3/STAT5 axis. | J Transl Med | 2023 | 36774517 | PubTator, text mining | PubMed |
| Genetics and Molecular Basis of Congenital Heart Defects in Down Syndrome: Role of Extracellular Matrix Regulation. | Int J Mol Sci | 2023 | 36769235 | PubTator, text mining | PubMed |
| Circular RNAs as a Diagnostic and Therapeutic Target in Cardiovascular Diseases. | Int J Mol Sci | 2023 | 36768449 | PubTator, text mining | PubMed |
| Aquaporin-5 Dynamic Regulation. | Int J Mol Sci | 2023 | 36768212 | PubTator, text mining | PubMed |
| RUNX1 Is Regulated by Androgen Receptor to Promote Cancer Stem Markers and Chemotherapy Resistance in Triple Negative Breast Cancer. | Cells | 2023 | 36766786 | PubTator, text mining | PubMed |
| RUNX3 in Stem Cell and Cancer Biology. | Cells | 2023 | 36766749 | PubTator, text mining | PubMed |
| Pediatric Acute Myeloid Leukemia Post Cytotoxic Therapy-Retrospective Analysis of the Patients Treated in Poland from 2005 to 2022. | Cancers (Basel) | 2023 | 36765692 | PubTator, text mining | PubMed |
| The structural basis for HIV-1 Vif antagonism of human APOBEC3G. | Nature | 2023 | 36754086 | Swiss-Prot, curated | PubMed |
| Germline Cancer Gene Expression Quantitative Trait Loci Are Associated with Local and Global Tumor Mutations. | Cancer Res | 2023 | 36745477 | PubTator, text mining | PubMed |
| Probable Treatment Targets for Diabetic Retinopathy Based on an Integrated Proteomic and Genomic Analysis. | Transl Vis Sci Technol | 2023 | 36745438 | PubTator, text mining | PubMed |
| High-expression of the innate-immune related gene UNC93B1 predicts inferior outcomes in acute myeloid leukemia. | Front Genet | 2023 | 36741319 | PubTator, text mining | PubMed |
| High risk-myelodysplastic syndrome following CAR T-cell therapy in a patient with relapsed diffuse large B cell lymphoma: A case report and literature review. | Front Oncol | 2023 | 36741006 | PubTator, text mining | PubMed |
| Chromobox proteins in cancer: Multifaceted functions and strategies for modulation (Review). | Int J Oncol | 2023 | 36734270 | PubTator, text mining | PubMed |
| Leukemic stem cells and therapy resistance in acute myeloid leukemia. | Haematologica | 2023 | 36722405 | PubTator, text mining | PubMed |
| Update on current treatments for adult acute myeloid leukemia: to treat acute myeloid leukemia intensively or non-intensively? That is the question. | Haematologica | 2023 | 36722404 | PubTator, text mining | PubMed |
Next-generation sequencing shows the genomic features of ovarian clear cell cancer and compares the genetic architectures of high-grade serous ovarian cancer and clear cell carcinoma in ovarian and endometrial tissues. | PeerJ | 2023 | 36721777 | PubTator, text mining | PubMed |
| Computational approaches for the design of modulators targeting protein-protein interactions. | Expert Opin Drug Discov | 2023 | 36715303 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/865/papers?page=20